Recent research also found that down-regulated CDC6 expression in bladder cancer cells and exosomes could inhibit the malignant processes of bladder cancer cells [43], revealing that targeting this exosome-derived gene might be a promising treatment strategy against tumours. Here, CDC6 is linked to urinary bladder carcinoma.